Skip to Content

Boston Scientific, U of M Sign Master Research Agreement

signing

Pictured: Schiestl (left) and Mulcahy sign the agreement at the Campus Club.

An agreement with Boston Scientific Corp. streamlines the process by which the medical device manufacturer awards research grants to the University of Minnesota. This is the first master research agreement to benefit from the provisions of Minnesota Innovation Partnerships, or MN-IP, the university’s new approach to the way it handles intellectual property arising from research projects funded by business and industry partners.

By setting standards for such items as intellectual property rights, publication process, liability, term and termination for all research contracts, the new master research agreement removes the need to renegotiate terms for every new research project. MN-IP eliminates the uncertainty and financial concerns that often surround industry-funded research projects, and offers an option for an exclusive worldwide license on any resulting IP — with royalties taking effect only in cases of significant commercial success.

“With this master research agreement, Boston Scientific and university researchers will be able to spend more time planning and performing research and less time on red tape,” says Tim Mulcahy, university vice president for research. “This is an important milestone in the university’s efforts to work more effectively with the business community, and we look forward to expanding what is already a very productive relationship with Boston Scientific.”

Specific projects will be identified on an ongoing basis and university researchers from a broad range of fields will carry out the work. In 2011, Boston Scientific invested a total of $895 million in research and development across its worldwide facilities.

“We are pleased to partner with the university in areas ranging from talent recruitment and training needs to research projects,” says Randy Schiestl, vice president, research and development in the Cardiac Rhythm Management group at Boston Scientific. “The MN-IP approach is a much more efficient and innovative way to approach a university partnership, and we look forward to future projects that may result.”

Post by John Merritt; Photos by Andria Waclawski

Originally published on Business @ the U of M

Gold block M

Contributing Writer

Latest Blog Posts

Sun setting over a prarie scene

After eight productive years, we are phasing out the Inquiry blog and launching a new monthly newsletter focused on news, information, and resources for our systemwide research community.

Read More
Dr. Friedemann-Sanchez and Dr. Grieve sitting at a table together.

In 2018, two University of Minnesota researchers traveled to a United Nations council meeting to advocate for changes to address an epidemic of violence against women in Colombia.

Read More
Senior man speaks with a health care provider while looking at a digital display

Researchers aim to help train pharmacists and educate patients with the goal of improving medication outcomes for groups with higher rates of kidney failure.

Read More
Sironix banner in a laboratory space

Sironix Renewables uses a patented method to make nontoxic, sustainably-sourced surfactants that replace their counterparts made from petroleum.

Read More

Announcements for the UMN Research Community